Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - July 2002

  1. Change Suggested in Hepatitis B Vaccinations for Infants Mich.Nurse 1999, 72 (8): 35.

  2. New Children's Vaccination Requirement Mich.Nurse 1999,
    72 (5): 4.

  3. Braun, R., Kimmig, P., and Hassler, D. Vaccination. Hepatitis B Dtsch.Med.Wochenschr. 5-17-2002, 127 (20): 1062. [Article in German]

  4. Braun, R. and Hassler, D. Vaccination. Hepatitis A Dtsch.Med.Wochenschr. 2002, 127 (16): 835. [Article in German]

  5. Christensen, L. S., Scholler, S., Schierup, M. H., Vestergaard, B. F., and Mordhorst, C. H. Sequence Analysis of Measles Virus Strains Collected During the Pre- and Early-Vaccination Era in Denmark Reveals a Considerable Diversity of Ancient Strains APMIS 2002, 110 (2): 113-122.

  6. Coughlan, S., Connell, J., Cohen, B., Jin, L., and Hall, W. W. Suboptimal Measles-Mumps-Rubella Vaccination Coverage Facilitates an Imported Measles Outbreak in Ireland Clin.Infect.Dis. 7-1-2002, 35 (1): 84-86.

  7. D'Lugoff, M. I. and Schalla, K. M. Vaccine Verification Guide: Demystifying Childhood Immunizations for Inpatient and Other Nurses Pediatr.Nurs. 2000, 26 (1): 69-75.

  8. Dvornikov, V. S. Diphtheria in the Republic of North Ossetia (Alania) Zh.Mikrobiol.Epidemiol.Immunobiol. 2002, 2): 79-81. [Article in Russian]

  9. Enserink, M. Bioterrorism. How Devastating Would a Smallpox Attack Really Be? Science 5-31-2002, 296 (5573): 1592-1595.

  10. Enserink, M. Bioterrorism. In Search of a Kinder, Gentler Vaccine Science 5-31-2002, 296 (5573): 1594.

  11. Ermolovich, M. A., Fel'dman, E. V., Samoilovich, E. O., Kuzovkova, N. A., and Levin, V. I. Characterization of the Immune Status of Patients With Vaccine-Associated Poliomyelitis Zh.Mikrobiol.Epidemiol.Immunobiol. 2002, 2): 42-50. [Article in Russian]

  12. Fasth, A. Infection Protection Requires Maintenance in a "Over-Hygienic" Surrounding World Lakartidningen 5-2-2002, 99 (18): 2069. [Article in Swedish]

  13. Feldman, R. Group B Streptococcus. Prevention of Infection in the Newborn Pract.Midwife. 2001, 4 (3): 16-18.

  14. Ghani, S. Convincing an Asian Community of the Importance of Flu Vaccination Prof.Nurse 2001, 17 (2): 130.

  15. Hino, M., Ono, Y., Kokubo, Y., Soma, T., Tanaka, Y., Omata, M., Ichino, K., Uehara, T., Kudoh, S., and Hayama, N. The Frequency Profiles of Size of Two-Step Tuberculin Skin Tests With Histories of BCG Vaccinations and Tuberculin Tests Among Hospital Employees Kekkaku 2002, 77 (4): 347-354. [Article in Japanese]

  16. Kaji, M., Watanabe, A., and Aizawa, H. Influenza Vaccination for Elderly Patients With Neurological Disease Kansenshogaku Zasshi 2002, 76 (4): 263-268. [Article in Japanese]

  17. Kuvakina, V. I., Golovina, L. I., Mishina, A. I., Skirda, T. A., Bobyleva, G. V., Mikheeva, N. G., Chernyshova, T. F., Temper, R. M., and Ermolenko, Z. N. Evaluation of the Immunological Activity and Safety of Group B Meningococcal Vaccine Prepared From a Natural Complex of Specific Polysaccharide and Outer Membrane Proteins Zh.Mikrobiol.Epidemiol.Immunobiol. 2002, 2): 33-37. [Article in Russian]

  18. Kyaw, M. H., Holmes, E. M., Chalmers, J., Jones, I. G., and Campbell, H. A Survey of Vaccine Coverage and Antibiotic Prophylaxis in Splenectomised Patients in Scotland J.Clin.Pathol. 2002, 55 (6): 472-474.

  19. Leask, J. Vaccination and Risk Communication: Summary of a Workshop, Arlington Virginia, USA, 5-6 October 2000 J.Paediatr.Child Health 2002, 38 (2): 124-128.

  20. Maiden, M. C. and Stuart, J. M. Carriage of Serogroup C Meningococci 1 Year After Meningococcal C Conjugate Polysaccharide Vaccination Lancet 5-25-2002, 359 (9320): 1829-1831.

  21. McIntyre, P., Amin, J., Gidding, H., Hull, B., Torvaldsen, S., Tucker, A., Turnbull, F., and Burgess, M. Vaccine Preventable Diseases and Vaccination Coverage in Australia, 1993-1998 Commun.Dis.Intell. 2000, Suppl:v-83. (): v-83.

  22. Ortolon, K. Short on Shots Tex.Med. 2002, 98 (5): 30-32.

  23. Pance, A., Reisser, D., and Jeannin, J. F. Antitumoral Effects of Lipid A: Preclinical and Clinical Studies J.Investig.Med. 2002, 50 (3): 173-178.

  24. Ramsay, M., White, J., and Crowcroft, N. MMR Uptake Data Are Unlikely to Be Subject to Manipulation BMJ 6-8-2002, 324 (7350): 1394.

  25. Scanlon-Kohlroser, C. A., Fan, P. Y., Primack, W., and Stoff, J. S. Primary Varicella After Transplantation Am.J.Kidney Dis. 2002, 39 (6): 1310-1312.

  26. Seibil', V. B. How Poliomyelitis Is to Be Eradicated Completely Zh.Mikrobiol.Epidemiol.Immunobiol. 2002, 2): 107-113. [Article in Russian]

  27. Staff, M. P. and Angel, P. A. Vaccination Among Household Contacts of Chronic Hepatitis B Carriers by General Practitioners Aust.Fam.Physician 2002, 31 (5): 491-493.

  28. Suzuki, M., Takizawa, A., Furuta, A., Yanada, S., Iwamuro, S., and Tashiro, K. A Case of Orchitis Following Vaccination With Freeze-Dried Live Attenuated Mumps Vaccine Nippon Hinyokika Gakkai Zasshi 2002, 93 (4): 577-579. [Article in Japanese]

  29. Tefanova, V. T., Tallo, T. G., Priimiagi, L. S., Kikosh, G. V., Krupskaia, L. M., Lisitsyna, S. A., and Noorlind, IuP Hepatitis A in Estonia (1990-1999) Zh.Mikrobiol.Epidemiol.Immunobiol. 2002, 2): 22-26. [Article in Russian]

  30. Verweij, M. Individual and Collective Considerations in Public Health: Influenza Vaccination in Nursing Homes Bioethics. 2001, 15 (5-6): 536-546.

Back to Top